Bharat Biotech to move to phase II trials for its Covid-19 vaccine

Bharat Biotech has received the clearance to move its vaccine candidate against Covid-19, Covaxin, to the second phase of human testing.

The trials are expected to begin in the coming week, following ethics committee approvals.

A subject expert committee (SEC) studying its request to begin the phase II trial recommended that the trial be conducted on 380 participants.


Leave a Reply

Your email address will not be published. Required fields are marked *

Our YouTube ChannelOur Facebook PageOur Twitter PageOur LinkedIn PageOur Instagram PageOur Whatsapp NumberYour Idea